These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26272850)

  • 21. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R; Ji Y; Vahle L; Sadowski G
    Mol Pharm; 2015 Aug; 12(8):2823-33. PubMed ID: 26107071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
    Sun Y; Tao J; Zhang GG; Yu L
    J Pharm Sci; 2010 Sep; 99(9):4023-31. PubMed ID: 20607809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A; Nies E; Van den Mooter G
    Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems.
    Rytting E; Lentz KA; Chen XQ; Qian F; Venkatesh S
    Pharm Res; 2004 Feb; 21(2):237-44. PubMed ID: 15032304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and stability of ternary solid dispersions with PVP and PHPMA.
    Al-Obaidi H; Ke P; Brocchini S; Buckton G
    Int J Pharm; 2011 Oct; 419(1-2):20-7. PubMed ID: 21801822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unified cosolvency model for calculating solute solubility in mixed solvents.
    Jouyban A; Chew NY; Chan HK; Sabour M; Acree WE
    Chem Pharm Bull (Tokyo); 2005 Jun; 53(6):634-7. PubMed ID: 15930773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures.
    Jouyban A
    J Pharm Pharm Sci; 2008; 11(1):32-58. PubMed ID: 18445363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A test of the transition-metal nanocluster formation and stabilization ability of the most common polymeric stabilizer, poly(vinylpyrrolidone), as well as four other polymeric protectants.
    Ott LS; Hornstein BJ; Finke RG
    Langmuir; 2006 Oct; 22(22):9357-67. PubMed ID: 17042554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2005 Oct; 303(1-2):54-61. PubMed ID: 16105723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solubility of hydrophobic compounds in water-cosolvent mixtures: relation of solubility with water-cosolvent interactions.
    Miyako Y; Zhao Y; Takeshima K; Kataoka T; Handa T; Pinal R
    J Pharm Sci; 2010 Jan; 99(1):293-302. PubMed ID: 19548311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new method to determine the partial solubility parameters of polymers from intrinsic viscosity.
    Bustamante P; Navarro-Lupión J; Escalera B
    Eur J Pharm Sci; 2005 Feb; 24(2-3):229-37. PubMed ID: 15661495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Taylor LS
    Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel polyvinylpyrrolidones to improve delivery of poorly water-soluble drugs: from design to synthesis and evaluation.
    Niemczyk AI; Williams AC; Rawlinson-Malone CF; Hayes W; Greenland BW; Chappell D; Khutoryanskaya O; Timmins P
    Mol Pharm; 2012 Aug; 9(8):2237-47. PubMed ID: 22738427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between water and poly(vinylpyrrolidone) containing polyethylene glycol.
    Hamaura T; Newton JM
    J Pharm Sci; 1999 Nov; 88(11):1228-33. PubMed ID: 10564074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.